AGENDA
- All
- Monday, October 21, 2024
- Tuesday, October 22, 2024
- Wednesday, October 23, 2024
Registration
Networking Breakfast
Welcome and Introduction
David Gaugh, RPh
Interim President & CEO, AAM
Dr. Janet Woodcock: A Legacy of Leadership
Join us for a special session reflecting on the remarkable career of Dr. Janet Woodcock, who recently retired from the U.S. Food and Drug Administration after 38 years of service. Dr. Woodcock been called one of the most powerful and influential drug regulators who has left a historic mark on the pharmaceutical industry and public health.
This session, hosted by Women in Health Policy (WiHP) and powered by the Association for Accessible Medicines (AAM), will dive into Dr. Woodcock’s impactful contributions to the generic and biosimilars industry and her legacy within the FDA. We will discuss her leadership, achievements, and the lasting impact of her work on drug regulation and accessibility.
Janet Woodcock, M.D.
Former Principal Deputy Commissioner, FDA
Moderator: David Gaugh, RPh
Interim President & CEO, AAM
Keynote Address
OGD Keynote Address
Iilun Murphy, M.D.
Director, Office of Generic Drugs (OGD), CDER FDA
Networking Break
GRx+Biosims Learning Tracks
Networking Luncheon
GRx+Biosims Learning Tracks
Networking Break
GRx+Biosims Learning Tracks
Networking Reception
Networking Breakfast
Science and Regulatory Working Group (members only)
Biosimilars Keynote Address
Sarah Yim, M.D.
Director, Office of Therapeutic Biologics and Biosimilars (OTBB), Office of New Drugs (OND), CDER, FDA
Keynote Address
ORA Keynote Address
Elizabeth Miller, PharmD
Assistant Commissioner for Medical Products and Tobacco Operations, Office of Regulatory Affairs (ORA), FDA
Networking Break
GRx+Biosims Learning Tracks
Networking Lunch
GRx+Biosims Learning Tracks
GRx+Biosims Exposition
An interactive knowledge sharing session that brings together multiple levels of scientific disciplines from diverse sectors, industry, academia and agency. The expo is geared toward facilitating one-on-one interaction among these sectors to increase understanding on a scientific level.
Biosimilars Council Meeting (members only)
Networking Reception
Dinner & Entertainment
Networking Breakfast
Keynote Address
Biosimilars Leadership Roundtable
Networking Break
General Session
CDER Keynote Address
Jacqueline Corrigan-Curay, JD, M.D.
Principal Deputy Center Director, Center for Drug Evaluation and Research (CDER), FDA
Networking Lunch
Conference Concludes
*Agenda is subject to change